BeStock  
Stocks › Biotechnology › SVRA

Savara SVRA

US equityMarket cap rank #3206Biotechnology
$4.26 −$0.95 (-18.23%)
Market closed · Nov 21, 9:10 am ET · Last extended-hours $4.30 +0.94%
Open$4.19
Prev close$5.21
Day range$4.00 – $4.52
Volume17.08M
Market cap$939.86M
P/E (TTM)–
Dividend yield–

Valuation

Multiples measured against the stock's own five-year history

Price / earnings-7.7x
CheapRich

Around its usual level · 57th percentile, 5-year average -8.7x

Price / book9.5x
CheapRich

Near the top of its 5-year range · 94th percentile, 5-year average 4.3x

#4909 of 5329 stocks by PB (1 = cheapest)

P/E over five years

-18x-12x-6x-1xOct '21Apr '24Nov '26

Dashed line is the 5-year average; the shaded band is one standard deviation either side.

Morningstar fair value estimate

Fair value$8.48
Price vs. fair value-49.8%Trading below the estimate
Star rating★★★★☆
Economic moatNone
UncertaintyVery High
MultipleCurrentForward5y averagePercentile vs. own historyIndustry rank
PB 9.49 – 4.30 94% (pricier than usual) #4909 of 5329 (1 = cheapest)
PE -7.73 -8.75 -8.67 57% (pricier than usual) –
PS – 23.92 15,853.81 – –

Percentile is against this stock’s own 5-year valuation range: higher means it’s trading rich relative to its own history, lower means cheap relative to its own history — it is not a comparison against other companies. Forward multiples use consensus estimates for the next twelve months; a forward multiple below the current one usually signals analysts expect earnings to grow.

Discussion

No comments yet — be the first to weigh in on SVRA.

Sign in to join the discussion.

Scroll to Top